MS
MSPRZ
MSP Recovery, Inc.
No data for this timeframe.
Vol
Inst. Holders1 funds
Inst. Value$1.7K
SEC Reports3
Recent Activity
May 18, 2026
SEC
Nasdaq has finalized the delisting of MSP Recovery, Inc. (MSPRZ) effective May 28, 2026, after the company failed to mee
25-NSE — Impact 9/10
Apr 20, 2026
SEC
MSP Recovery secured two one-time emergency advances totaling $235,000 from its existing lenders Hazel Partners and VRM
8-K — Impact 7/10
Apr 6, 2026
SEC
MSP Recovery secured two one-time, non-committed advances totaling $250,000 from its existing lenders, Hazel Partners an
8-K — Impact 7/10
Latest Reports
BEARISH
25-NSE
9/10
Nasdaq has finalized the delisting of MSP Recovery, Inc. (MSPRZ) effective May 28, 2026, after the company failed to mee
May 18, 2026
BEARISH
8-K
7/10
MSP Recovery secured two one-time emergency advances totaling $235,000 from its existing lenders Hazel Partners and VRM
Apr 20, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| CITADEL ADVISORS LLC | $1.7K | — |
1 institutional holders with $1.7K total value (41,629 shares) as of 2025-Q1. Top holders: CITADEL.
Top Institutional Holders — 2025-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | 41,629 | $1.7K | 100.0% | — |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 0 bullish, 3 bearish, 0 mixed, 0 neutral. Avg impact: 7.7/10.
BEARISH
25-NSE
9/10
Nasdaq has finalized the delisting of MSP Recovery, Inc. (MSPRZ) effective May 28, 2026, after the c
May 18, 2026
BEARISH
8-K
7/10
MSP Recovery secured two one-time emergency advances totaling $235,000 from its existing lenders Haz
Apr 20, 2026
BEARISH
8-K
7/10
MSP Recovery secured two one-time, non-committed advances totaling $250,000 from its existing lender
Apr 6, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.